Literature DB >> 24910285

Biointegration of corneal macroporous membranes based on poly(ethyl acrylate) copolymers in an experimental animal model.

Jorge L Alió del Barrio1, Massimo Chiesa, Gloria Gallego Ferrer, Nerea Garagorri, Nerea Briz, Jorge Fernandez-Delgado, Maria Sancho-Tello Valls, Carmen Carda Botella, Ignacio García-Tuñón, Laurent Bataille, Alejandra Rodriguez, Francisco Arnalich-Montiel, Jose L Gómez Ribelles, Carmen M Antolinos-Turpín, Jose A Gómez-Tejedor, Jorge L Alió, Maria P De Miguel.   

Abstract

Currently available keratoprosthesis models (nonbiological corneal substitutes) have a less than 75% graft survival rate at 2 years. We aimed at developing a model for keratoprosthesis based on the use of poly(ethyl acrylate) (PEA)-based copolymers, extracellular matrix-protein coating and colonization with adipose-derived mesenchymal stem cells. Human adipose tissue derived mesenchymal stem cells (h-ADASC) colonization efficiency of seven PEA-based copolymers in combination with four extracellular matrix coatings were evaluated in vitro. Then, macroporous membranes composed of the optimal PEA subtypes and coating proteins were implanted inside rabbit cornea. After a 3-month follow-up, the animals were euthanized, and the clinical and histological biointegration of the implanted material were assessed. h-ADASC adhered and survived when cultured in all PEA-based macroporous membranes. The addition of high hydrophilicity to PEA membranes decreased h-ADASC colonization in vitro. PEA-based copolymer containing 10% hydroxyethyl acrylate (PEA-HEA10) or 10% acrylic acid (PEA-AAc10) monomeric units showed the best cellular colonization rates. Collagen plus keratan sulfate-coated polymers demonstrated enhanced cellular colonization respect to fibronectin, collagen, or uncoated PEAs. In vivo implantation of membranes resulted in an extrusion rate of 72% for PEA, 50% for PEA-AAc10, but remarkably of 0% for PEA-HEA10. h-ADASC survival was demonstrated in all the membranes after 3 months follow-up. A slight reduction in the extrusion rate of h-ADASC colonized materials was observed. No significant differences between the groups with and without h-ADASC were detected respect to transparency or neovascularization. We propose PEA with low hydroxylation as a scaffold for the anchoring ring of future keratoprosthesis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  adipose derived stem cells; cornea; corneal scaffold; macroporous membranes; poly(ethyl acrylate)

Mesh:

Substances:

Year:  2014        PMID: 24910285     DOI: 10.1002/jbm.a.35249

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  5 in total

Review 1.  Corneal surgery in keratoconus: which type, which technique, which outcomes?

Authors:  Francisco Arnalich-Montiel; Jorge L Alió Del Barrio; Jorge L Alió
Journal:  Eye Vis (Lond)       Date:  2016-01-18

Review 2.  Cellular therapy of the corneal stroma: a new type of corneal surgery for keratoconus and corneal dystrophies.

Authors:  Jorge L Alió Del Barrio; Jorge L Alió
Journal:  Eye Vis (Lond)       Date:  2018-11-01

Review 3.  Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits.

Authors:  Martine Tarsitano; Maria Chiara Cristiano; Massimo Fresta; Donatella Paolino; Concetta Rafaniello
Journal:  Gels       Date:  2022-07-10

Review 4.  Corneal Regeneration Using Adipose-Derived Mesenchymal Stem Cells.

Authors:  Jorge L Alió Del Barrio; Ana De la Mata; María P De Miguel; Francisco Arnalich-Montiel; Teresa Nieto-Miguel; Mona El Zarif; Marta Cadenas-Martín; Marina López-Paniagua; Sara Galindo; Margarita Calonge; Jorge L Alió
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

Review 5.  Femtosecond laser-assisted implantation of corneal stroma lenticule for keratoconus.

Authors:  Adriano Fasolo; Alice Galzignato; Emilio Pedrotti; Chiara Chierego; Tiziano Cozzini; Erika Bonacci; Giorgio Marchini
Journal:  Int Ophthalmol       Date:  2021-02-24       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.